FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/09/027693 [Registered on: 10/09/2020] Trial Registered Prospectively
Last Modified On: 02/09/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Ayurvedic Treatment for Allergic Conjunctivitis  
Scientific Title of Study   Efficacy Of Nimbalodhra Kwatha Seka In The Management Of Vataja Abhishyanda W.S.R To Simple Allergic Conjunctivitis A Randomized Controlled Clinical Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Prathibha Prakash 
Designation  PG Scholar 
Affiliation  KAHERS Shri BM Kankanwadi Ayurveda Mahavidyalaya 
Address  Dr Prathibha Prakash PG Scholar Department Of Shalakya Tantra KAHERS Shri BM Kankanwadi Ayurveda Mahavidyalaya , Shahapur, Belgaum

Belgaum
KARNATAKA
590003
India 
Phone  9742561473  
Fax    
Email  prathibha4prakash@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Meghana B Patil 
Designation  Assistant Professor 
Affiliation  KAHERS Shri BM Kankanwadi Ayurveda Mahavidyalaya 
Address  Department Of Shalakya Tantra KAHERS Shri BM Kankanwadi Ayurveda Mahavidyalaya Shahapur Belgaum

Belgaum
KARNATAKA
590003
India 
Phone  9742561473  
Fax    
Email  megs816@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Meghana B Patil 
Designation  Assistant Professor 
Affiliation  KAHERS Shri BM Kankanwadi Ayurveda Mahavidyalaya 
Address  Department Of Shalakya Tantra KAHERS Shri BM Kankanwadi Ayurveda Mahavidyalaya Shahapur Belgaum

Belgaum
KARNATAKA
590003
India 
Phone  9742561473  
Fax    
Email  megs816@gmail.com  
 
Source of Monetary or Material Support  
KLE ACADEMY OF HIGHER EDUCATION AND RESEARCHES OWNED SHRI BM KANKANAWADI AYURVEDA MAHAVIDYALAYA AND KLE AYURVEDA HOSPITAL  
 
Primary Sponsor  
Name  Dr Prathibha Prakash 
Address  Dr Prathibha Prakash PG Scholar Department Of Shalakya Tantra KAHERS Shri BM Kankanwadi Ayurveda Mahavidyalaya shahapur Belgaum 
Type of Sponsor  Other [Self Sponsored PG Dessertation] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prathibha Prakash  OPD No 27  Department of Shalakya Tantra KAHERS Shri BM Kankanwadi Ayurveda Mahavidyalaya and Hospital
Belgaum
KARNATAKA 
9742561473

prathibha4prakash@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE FOR RESEARCH ON HUMAN SUBJECTS SHRI BMK AYURVEDA MAHAVIDYALAYA & HOSPITAL SHAHAPUR BELAGAVI  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H108||Other conjunctivitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nimbalodhra kwatha   Nimba Lodhra kwatha seka will be done for 7 days  
Comparator Agent  Triphaladi kwatha   Triphaladi kwatha seka will be done for 7 days  
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients presenting with signs and symptoms of clinically established Vataja Abhishyanda and fulfilling the diagnostic criteria
Patients with age group of 12 to 60yrs
Patients of either sex
 
 
ExclusionCriteria 
Details  Patients suffering from vernal Kerato conjunctivitis Atopic Kerato conjunctivitis Giant papillary conjunctivitis.
Patients having complicated eye diseases, Trachoma, Chalazion, Stye, Pterygium, Dacryocystitis, Trichiasis, etc.
Patients suffering from Corneal Opacity, Ulcers.
Diagnosed cases of Glaucoma and any ophthalmic infective conditions will be excluded.
Patients with other systemic disorders like renal diseases, uncontrolled hyperglycemia and hyperlipidemia, cardiovascular diseases etc will be excluded.
Extremely debilitated patients and in pregnancy.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Nimbalodhra kwatha seka is effective in the management of Vataja Abhishyanda w.s.r to Simple Allergic Conjunctivitis  18 months 
 
Secondary Outcome  
Outcome  TimePoints 
Nimbalodhra kwatha seka is more effective than Triphaladi kwatha seka in the management of Vataja Abhishyanda w.s.r to Simple Allergic Conjunctivitis  18 months  
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   01/11/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
TTThe  study is to evaluate the efficacy of Nimbalodhra kwatha seka in the management of Vataja Abhishyanda w.s.r.t Allergic Conjunctivitis and to compare with Triphaladi kwatha seka when done for  a  period of 7 days. The study will be conducted at KAHERS Shri BM Kankanawadi Ayurveda Mahavidyalaya and Research Center owned KLE Ayurveda Hospital Shahapur Belgavi Karnataka India. The expected outcome is to reduce the signs and symptoms of Vataja Abhishyanda w s r to Allergic Conjunctivitis and to  prove that nimbalodhra kwatha seka is more efficacous .
 
Close